JENNISON ASSOCIATES LLC 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 09:12 am Purchase |
2024-09-30 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
JENNISON ASSOCIATES LLC | 2,178,580 5.700% |
2,178,580 (New Position) |
Filing |